Skip to content

Discontinued — last reported Q3 '23

Gross Profit at other companies

Eli Lilly logo
Eli LillyLLY
$16.22B+54.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$230.92M-2.9%
uniQure logo
uniQureQURE
$3.34M+144%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1.98B-1.7%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
$72.6M-5.3%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

The official record: Perspective Therapeutics’s 10-Q, filed November 14, 2023, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's gross profit?
Perspective Therapeutics (CATX) reported gross profit of $738K in Q3 2023.
How has Perspective Therapeutics's gross profit changed year-over-year?
Perspective Therapeutics's gross profit increased by 78.3% year-over-year, from $414K to $738K.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.